Köves K, Arimura A
US-Japan Biomedical Research Laboratories, Tulane University, Belle Chasse, Louisiana 70037.
J Histochem Cytochem. 1989 Jun;37(6):903-8. doi: 10.1177/37.6.2723405.
We have developed a novel and simple method, requiring only a small amount of antigen, for removal of undesired antibodies from antiserum. The method was established using a well-characterized antiserum against rat luteinizing hormone (anti-rLH). Wells of polystyrene tissue culture plates were coated with rat LH (rLH). Anti-rLH diluted 1:3000 was added to rLH-coated wells and shaken to remove LH antibodies. Control anti-rLH was treated in a similar manner in non-rLH-coated wells. Both antisera were tested by immunocytochemistry on rat pituitaries. Antiserum from rLH-coated wells stained no cells, whereas the control serum stained cells that were morphologically typical of LH cells. The effectiveness of this antibody removal was also confirmed in a modified ELISA. In another experiment, anti-rLH and anti-hTSH beta sera were mixed. The final dilution of both antisera was 1:10,000. Anti-rLH was removed by the purification method described. Completeness of antibody removal was confirmed by a double-immunohistochemical staining of rat pituitary in which sections were first stained by the PAP method and then stained with an immunofluorescence procedure after elution of the first antigen-antibody complex. The mixed antiserum incubated in rLH-coated wells did not stain LH cells. There was no co-localization between the LH immunopositivity demonstrated by an anti-rLH serum using immunofluorescence and cells immunostained with the purified antiserum using the PAP method. As indicated in ELISA, the titer of the TSH beta antiserum was not decreased compared to that of the untreated, mixed control antiserum, and the LH antibodies were eliminated by the treatment. This new purification method has four distinct advantages: (a) antiserum is not treated chemically; (b) it requires only a small amount of antigen compared with the amount required for affinity chromatography; (c) neither the undesired antigen-antibody complex(es) nor an excess amount of antigen is present in the purified antiserum; and (d) removal of undesired antibodies can be monitored by ELISA.
我们开发了一种新颖且简单的方法,只需少量抗原,即可从抗血清中去除不需要的抗体。该方法是利用一种针对大鼠促黄体生成素(抗rLH)的特性明确的抗血清建立的。将大鼠促黄体生成素(rLH)包被在聚苯乙烯组织培养板的孔中。将稀释至1:3000的抗rLH加入到包被有rLH的孔中并振荡,以去除LH抗体。对照抗rLH在未包被rLH的孔中以类似方式处理。两种抗血清都通过对大鼠垂体进行免疫细胞化学检测。来自包被有rLH的孔的抗血清未对任何细胞染色,而对照血清对形态上典型的LH细胞进行了染色。这种抗体去除的有效性在改良的ELISA中也得到了证实。在另一项实验中,将抗rLH和抗hTSHβ血清混合。两种抗血清的最终稀释度均为1:10,000。通过所述纯化方法去除抗rLH。通过对大鼠垂体进行双重免疫组织化学染色来确认抗体去除的完整性,其中切片首先通过PAP法染色,然后在洗脱第一种抗原 - 抗体复合物后用免疫荧光程序染色。在包被有rLH的孔中孵育的混合抗血清未对LH细胞染色。使用免疫荧光的抗rLH血清显示的LH免疫阳性与使用PAP法用纯化抗血清免疫染色的细胞之间没有共定位。如ELISA所示,与未处理的混合对照抗血清相比,TSHβ抗血清的效价没有降低,并且通过处理消除了LH抗体。这种新的纯化方法有四个明显的优点:(a)抗血清不进行化学处理;(b)与亲和层析所需的抗原量相比,它只需要少量抗原;(c)纯化的抗血清中既不存在不需要的抗原 - 抗体复合物,也不存在过量的抗原;(d)可以通过ELISA监测不需要的抗体的去除情况。